SCHEMBL12377638

SCHEMBL12377638

Cc1noc(-c2ccc(Cl)cc2)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.48
KDM4E B2RXH2 2/20 0.48
EDNRB P24530 1/20 0.45
EDNRA P25101 1/20 0.45
NR1H4 Q96RI1 1/20 0.43
TP53 P04637 1/20 0.42
ALDH1A1 P00352 6/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
FFAR4 Q5NUL3 1/20 0.41
TSHR P16473 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
HPGD P15428 1/20 0.41
POLB P06746 1/20 0.41
ALOX5AP P20292 1/20 0.40
BRD4 O60885 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16021584 0.83 MAPT (0.47) MAPTKDM4EEDNRBEDNRANR1H4
SCHEMBL27886960 0.80 EDNRB (0.45) MAPTEDNRBEDNRANR1H4TP53
SCHEMBL3751072 0.79 BRD4 (0.53) MAPTKDM4EEDNRBEDNRATP53
SCHEMBL2818112 0.78 ALDH1A1 (0.41) MAPTKDM4ENR1H4TP53ALDH1A1
SCHEMBL27787586 0.77 ALDH1A1 (0.40) MAPTKDM4ENR1H4ALDH1A1SMN1; SMN2
SCHEMBL11518747 0.75 MAPT (0.51) MAPTKDM4EALDH1A1SMN1; SMN2FFAR4
SCHEMBL4336589 0.75 MAPT (0.51) MAPTKDM4EALDH1A1SMN1; SMN2FFAR4
SCHEMBL1686250 0.75 ALOX5 (0.53) MAPTKDM4EALDH1A1SMN1; SMN2FFAR4
SCHEMBL13615437 0.72 MAPT (0.57) MAPTKDM4ETP53ALDH1A1SMN1; SMN2
SCHEMBL27517207 0.72 ALOX5AP (0.49) MAPTKDM4EALDH1A1SMN1; SMN2ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989394-B2 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds BASF SE (DE) 2011-08-02 US disclosed
US-20090131256-A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane Compounds BASF SE (DE) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131256-A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane Compounds AAAS, AIPL1, ATXN2 MAPT 4268/4885KDM4E 2042/4885EDNRB 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.